Volume 26, Issue 117 (9-2018)                   J Adv Med Biomed Res 2018, 26(117): 21-31 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

S E P, S M, A M, Z E, M D. The Efficacy of Matrix Model Treatment in the Reduction of Addiction Severity and Relapse Prevention among Amphetamine Abusers . J Adv Med Biomed Res. 2018; 26 (117) :21-31
URL: http://zums.ac.ir/journal/article-1-5402-en.html
Abstract:   (2311 Views)
Background and Objective: Amphetamine abuse has become a major problem in recent years. The aim of this study was to examine the efficacy of Matrix Model treatment in  amphetamine abusers.
Materials and Methods: This study was a clinical trial with a pretest-posttest design. The study population included all known abusers of amphetamines in Zanjan, Iran.The sample consisted of 40 people referring to local psychiatric and psychological clinics. They were chosen based on convenient sampling and were randomly assigned into two groups, pharmacotherapy and combined therapy (pharmacotherapy and Matrix Model treatment). ASI questionnaires and urinary tests were administered before and after treatment and the data were analyzed using ANCOVA and chi-squared tests.
Results: The treatment was effective when considering job status, drug and alcohol abuse, salary, family and mental status (p= 0/001). In terms of the medical status of addiction severity, there was no significant difference between the two groups. Chi test showed that the frequency of positive urinary tests decreased in the combined therapy group (p= 0/05).
Conclusion: Results suggest that the Matrix Model Treatment can reduce addiction severity and can also reduce the frequency of positive urinary tests.
 

 
Full-Text [PDF 3028 kb]   (891 Downloads)    
Type of Study: Original |
Received: 2018/11/10 | Accepted: 2018/11/10 | Published: 2018/11/10

References
1. References
2. Allahverdipour H, Bazargan M, Farhadinasab A, Hidarnia A, Bashirian S. Effectiveness of skillbased substance abuse intervention among male adolescents in an Islamic country: Case of the Islamic Republic of Iran. J Drug Educ. 2009; 39: 211-22.
3. Sadock BJ, Sadock VA. Comprehensive textbook of psychiatry. 2rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999: 924-5.
4. Tofani H, Javanbakht M. Comparison adoption styles and attitudes among drug abusers and control Groups. J Sabzevar Univ Med Sci. 2003; 9: 70-9.
5. Sajjadi M, Shariatifar N, Matlabi M, Abbasnezhad AA, Basiri K, Nazemi H. The rate of knowledge and attitude toward psychoactive drugs and its abuse prevalence in Gonabad University students. Ofogh-e-Danesh. 2009; 15: 58-65.
6. Leung KS, Abdallah AB, Copeland J, Cottler LB. Modifiable risk factors of ecstasy use: Risk perception, current dependence, perceived control, and depression. Addict Behav. 2010; 35: 201-8.
7. Schydlower M. Substance abuse, a guide for health professional’s Pediatrics, dedicated to the health of all children. 2rd ed. Illinois: American Academy of Pediatrics; 2002: 235.
8. Seyyed Fatemi N, Khoshnavaye Foomani F, Behbahani N, Hosseini F. Assertiveness skill and use of ecstasy among Iranian adolescents. Fundamentals of mental health. 2007; 10: 265-72.
9. Hadadi R. On the comparison of the therapeutic effects of matrix treatment on severity of addiction and mental health between female and male methamphetamine abusers. Res Addict. 2015: 8: 57-69.
10. Mokri Azarakhsh. Manual treatment of drug abuse stimulus: Based on the modified pattern quarter Matryks-Vyrastary. 4. 2013.
11. Taheri Nakhost H, Gilani Pour, Manual of psychological intervention on outpatient treatment of stimulant use disorders Matrix model: the leaves Nshrspyd, 2013.
12. Rawson R. An intensive outpatient approach for cocaine abuse treatment: The matrix model. J Substance Abuse Treat. 1995: 12: 117-27.
13. Marlatt G, Gordon J. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. New York: Guilford;
15. Rawson RA, Obert JL, McCann MJ, Mann AJ. Cocaine treatment outcome: Cocaine use following inpatient, outpatient and no treatment. NIDA Res Monograph. 1986; 67: 271-77.
16. Shoptaw S, Frosch D, Rawson R, Ling W. Cocaine abuse counseling as HIV prevention. J AIDS Educ Prevent. 1997; 9: 511-20.
17. Jafari Nejad M. The effectiveness of treatment based on outpatient deep matrix model and stages of change on improvement of self-regulation and self-efficacy of drug abstinence. Thought Behav Clin Psychol. 2015: 9: 47-56.
18. Jeanne L Obert, Michael J, Mc Cann, et al. The matrix model of outpatient stimulant abuse treatment: History and Descriptio: 2011.
19. Shoptaw S, Rawson RA, MC Cann MJ, Obert J. The matrix model of outpatient stimulant abuse treatment:Evidence of efficacy.J Addictive Diseases.1995.13:129-41
20. Pates R, Riley D. Interventions for Amphetamine Misuse. United States: Blackwell publishing LTD. 2010.
21. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiat. 2004, 185: 196-204
22. Ashouri A, Mohammadi N. The effectiveness of cognitive-behavioral group therapy on the improvement of coping skills and relapse prevention in addicted individuals. Iran J Psychiat Clin Psychol. 14: 281-88.
23. Tajeri B. The effectiveness of CBT in the reduction craving and relapse prevention among amphetamine abusers. Thought Behav Clin Psychol. 39: 27-36.
24. Turkcapar H, Kose S, Ince A, Myrick H. Beliefs as a predictors of relapse in alcohol dependence Turkish men. J Study Alcohol. 2008; 66: 848-51.
25. Frisch MB. Quality or life therapy. Trans Lated By: Khamse A. Tehran: Arjmand Press; 2011. In Persian. strength, functional ankle instability, comprehensive combined program.

Add your comments about this article : Your username or Email:
CAPTCHA

© 2019 All Rights Reserved | J Adv Med Biomed Res

Designed & Developed by : Yektaweb  Co-Publisher: Farname Inc.